Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Niagen Bioscience (NAGE) over the last 12 years, with Q3 2025 value amounting to $564000.0.

  • Niagen Bioscience's Interest & Investment Income rose 10434.78% to $564000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 8766.86%. This contributed to the annual value of $1.1 million for FY2024, which is 7080.18% up from last year.
  • Niagen Bioscience's Interest & Investment Income amounted to $564000.0 in Q3 2025, which was up 10434.78% from $552000.0 recorded in Q2 2025.
  • Niagen Bioscience's Interest & Investment Income's 5-year high stood at $564000.0 during Q3 2025, with a 5-year trough of $125000.0 in Q2 2023.
  • Moreover, its 3-year median value for Interest & Investment Income was $279000.0 (2023), whereas its average is $329900.0.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first surged by 3226.95% in 2024, then skyrocketed by 12904.56% in 2025.
  • Over the past 3 years, Niagen Bioscience's Interest & Investment Income (Quarter) stood at $282000.0 in 2023, then soared by 32.27% to $373000.0 in 2024, then skyrocketed by 51.21% to $564000.0 in 2025.
  • Its Interest & Investment Income stands at $564000.0 for Q3 2025, versus $552000.0 for Q2 2025 and $459000.0 for Q1 2025.